• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 12th September 2013

Third Edition of OHE’s Guide to Health Economic Evaluation Released

OHE today released the third edition of its popular primer, Health Economics: An Introduction to Economic Evaluation, authored by Gisela Kobelt, who has extensive hands-on experience in the field. What distinguishes this book from other such reviews are the fifteen…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Health Economics: An Introduction to Economic Evaluation

OHE today released the third edition of its popular primer, Health Economics: An Introduction to Economic Evaluation, authored by Gisela Kobelt, who has extensive hands-on experience in the field. What distinguishes this book from other such reviews are the fifteen concrete study examples that focus on pharmaceuticals The book traces the development of the field of health technology assessment (HTA), discusses current requirements for HTA in a number of health care systems around the world, and offers guidance as to which approach is appropriate in what situations.

Health Economics: An Introduction to Economic Evaluation

OHE today released the third edition of its popular primer, Health Economics: An Introduction to Economic Evaluation, authored by Gisela Kobelt, who has extensive hands-on experience in the field. What distinguishes this book from other such reviews are the fifteen concrete study examples that focus on pharmaceuticals.

The book traces the development of the field of health technology assessment (HTA), discusses current requirements for HTA in a number of health care systems around the world, and offers guidance as to which approach is appropriate in what situations. The study examples highlight the challenges that various approaches must overcome in application and suggest solutions. Included are cost-of-illness studies, cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis.

The value of the primer is highlighted by the continuing popularity of the second edition, even after a decade. Adrian Towse, Director of the OHE, said: “We are delighted to offer this expanded and updated third edition, which will attract a wide audience. Written in an accessible style, it will provide important background both for those who undertake evaluations and those who use them in decision making in the public and private sectors. We also expect the guide to be useful to policy makers and health care policy analysts who wish to know more about HTA and its proper uses.”

Download: Kobelt, G. (2013) Health Economics: An Introduction to Economic Evaluation. London: Office of Health Economics.

This book also is available as an on-demand, printed publication. Click here to place an order. Note that this service has stores in several countries, which you can select by clicking on the flag at the top of the page.

  • Health Technology Assessment…
  • Monograph

Related News

  • News
  • January 2019

Can a Strong Economic Case Be Made for Investing in the NHS? 25th Annual Lecture Publication

Read more
The Challenges and Economics of Drug Development in 2022
  • News
  • July 2013

Forecasting the Challenges and Economics of Drug Development in 2022

Read more
The R&D Cost of a New Medicine
  • News
  • December 2012

OHE Study on Pharmaceutical R&D Costs Released

Read more
Prof Tony Culyer
  • News
  • November 2012

Collected Essays by Tony Culyer on Health Economics

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!